The University of Southampton
University of Southampton Institutional Repository

Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohort

Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohort
Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohort
Background and hypothesis: many non-modifiable factors are associated with poorer health-related quality of life (HRQoL) experienced by people with chronic kidney disease (CKD). We hypothesise that potentially modifiable factors for poor HRQoL can be identified among CKD patients, providing potential targets for intervention.

Method: the NURTuRE-CKD cohort study recruited 2996 participants from nephrology centres with all stages of non-dialysis dependent CKD. Baseline data collection for sociodemographic, anthropometric, biochemical, and clinical information, including Integrated Palliative care Outcome Scale renal (IPOS), Hospital Anxiety and Depression score (HADS), and EQ-5D-5L as HRQoL measure, took place between 2017-2019. EQ-5D-5L dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) were mapped to an EQ-5D-3L value set to derive index value. Multivariable mixed effects regression models, adjusted for known factors affecting HRQoL with recruitment region as a random effect, were fit to assess potentially modifiable factors associated with index value (linear) and within each dimension (logistic).

Results: among the 2958/2996 (98.7%) participants with complete EQ-5D data, 2201 (74.4%) reported problems in at least one EQ-5D-5L dimension. Multivariable linear regression identified independent associations between poorer HRQoL (EQ-5D-3L index value) and obesity (body mass index≥30.0kg/m2, β-0.037 , 95%CI -0.058 to -0.016, p=0.001), HADS depression score ≥8 (β-0.159, -0.182 to -0.137, p=<0.001), anxiety score ≥8 (β-0.090, -0.110 to -0.069, p=<0.001), taking ≥10 medications (β-0.065, -0.085 to -0.046, p=<0.001), sarcopenia (β-0.062, -0.080 to - 0.043, p=<0.001) haemoglobin <100g/L (β-0.047, -0.085 to -0.010, p=0.012) and pain (β-0.134,-0.152 to -0.117, p=<0.001). Smoking and prescription of prednisolone independently associated with problems in self-care and usual activities respectively. Renin-angiotensin system inhibitor (RASi) prescription associated with fewer problems with mobility and usual activities.

Conclusion: potentially modifiable factors including obesity, pain, depression, anxiety, anaemia, polypharmacy, smoking, steroid use, and sarcopenia associated with poorer HRQoL in this cohort, whilst RASi use was associated with better HRQoL in two dimensions.
Quality of life, Chronic kidney disease
2048-8513
Phillips, Thomas
30ef6ddd-1f4a-4791-89e5-37c092fcba51
Harris, Scott
19ea097b-df15-4f0f-be19-8ac42c190028
Aiyegbusi, Olalekan Lee
45b4713d-c1dd-4b1f-9547-542d6d55d0c1
Lucas, Bethany
73b79c04-5574-4976-b75e-ba6615f874e1
Benavente, Melissa
1e213839-f9de-4d96-a02f-13915cccce6c
Roderick, Paul J.
dbb3cd11-4c51-4844-982b-0eb30ad5085a
Cockwell, Paul
0139df0c-313f-41fe-a098-21585876b827
Kalra, Philip A.
8aa743e7-a8bd-4f25-bea5-2d23432c1e36
Wheeler, David C.
7ba656e2-c874-4520-9d6e-a5fde2921ee8
Taal, Maarten W.
10eeea62-a2fc-43b6-b5af-359e75c501ea
Fraser, Simon D.S.
135884b6-8737-4e8a-a98c-5d803ac7a2dc
Phillips, Thomas
30ef6ddd-1f4a-4791-89e5-37c092fcba51
Harris, Scott
19ea097b-df15-4f0f-be19-8ac42c190028
Aiyegbusi, Olalekan Lee
45b4713d-c1dd-4b1f-9547-542d6d55d0c1
Lucas, Bethany
73b79c04-5574-4976-b75e-ba6615f874e1
Benavente, Melissa
1e213839-f9de-4d96-a02f-13915cccce6c
Roderick, Paul J.
dbb3cd11-4c51-4844-982b-0eb30ad5085a
Cockwell, Paul
0139df0c-313f-41fe-a098-21585876b827
Kalra, Philip A.
8aa743e7-a8bd-4f25-bea5-2d23432c1e36
Wheeler, David C.
7ba656e2-c874-4520-9d6e-a5fde2921ee8
Taal, Maarten W.
10eeea62-a2fc-43b6-b5af-359e75c501ea
Fraser, Simon D.S.
135884b6-8737-4e8a-a98c-5d803ac7a2dc

Phillips, Thomas, Harris, Scott, Aiyegbusi, Olalekan Lee, Lucas, Bethany, Benavente, Melissa, Roderick, Paul J., Cockwell, Paul, Kalra, Philip A., Wheeler, David C., Taal, Maarten W. and Fraser, Simon D.S. (2023) Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohort. Clinical Kidney Journal. (In Press)

Record type: Article

Abstract

Background and hypothesis: many non-modifiable factors are associated with poorer health-related quality of life (HRQoL) experienced by people with chronic kidney disease (CKD). We hypothesise that potentially modifiable factors for poor HRQoL can be identified among CKD patients, providing potential targets for intervention.

Method: the NURTuRE-CKD cohort study recruited 2996 participants from nephrology centres with all stages of non-dialysis dependent CKD. Baseline data collection for sociodemographic, anthropometric, biochemical, and clinical information, including Integrated Palliative care Outcome Scale renal (IPOS), Hospital Anxiety and Depression score (HADS), and EQ-5D-5L as HRQoL measure, took place between 2017-2019. EQ-5D-5L dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) were mapped to an EQ-5D-3L value set to derive index value. Multivariable mixed effects regression models, adjusted for known factors affecting HRQoL with recruitment region as a random effect, were fit to assess potentially modifiable factors associated with index value (linear) and within each dimension (logistic).

Results: among the 2958/2996 (98.7%) participants with complete EQ-5D data, 2201 (74.4%) reported problems in at least one EQ-5D-5L dimension. Multivariable linear regression identified independent associations between poorer HRQoL (EQ-5D-3L index value) and obesity (body mass index≥30.0kg/m2, β-0.037 , 95%CI -0.058 to -0.016, p=0.001), HADS depression score ≥8 (β-0.159, -0.182 to -0.137, p=<0.001), anxiety score ≥8 (β-0.090, -0.110 to -0.069, p=<0.001), taking ≥10 medications (β-0.065, -0.085 to -0.046, p=<0.001), sarcopenia (β-0.062, -0.080 to - 0.043, p=<0.001) haemoglobin <100g/L (β-0.047, -0.085 to -0.010, p=0.012) and pain (β-0.134,-0.152 to -0.117, p=<0.001). Smoking and prescription of prednisolone independently associated with problems in self-care and usual activities respectively. Renin-angiotensin system inhibitor (RASi) prescription associated with fewer problems with mobility and usual activities.

Conclusion: potentially modifiable factors including obesity, pain, depression, anxiety, anaemia, polypharmacy, smoking, steroid use, and sarcopenia associated with poorer HRQoL in this cohort, whilst RASi use was associated with better HRQoL in two dimensions.

Text
Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohort - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (999kB)

More information

Accepted/In Press date: 22 December 2023
Additional Information: OLA receives funding from the National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre (BRC), NIHR Applied Research Collaboration (ARC), West Midlands, NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics at the University of Birmingham and University Hospitals Birmingham NHS Foundation, The Health Foundation, Innovate UK (part of UK Research and Innovation), Gilead Sciences Ltd, Merck, Anthony Nolan, and Sarcoma UK. OLA declares personal fees from Gilead Sciences Ltd, GlaxoSmithKline (GSK) and Merck outside the submitted work.
Keywords: Quality of life, Chronic kidney disease

Identifiers

Local EPrints ID: 485966
URI: http://eprints.soton.ac.uk/id/eprint/485966
ISSN: 2048-8513
PURE UUID: f4cd5949-94f4-4570-b01e-cf31bff52453
ORCID for Paul J. Roderick: ORCID iD orcid.org/0000-0001-9475-6850
ORCID for Simon D.S. Fraser: ORCID iD orcid.org/0000-0002-4172-4406

Catalogue record

Date deposited: 04 Jan 2024 17:30
Last modified: 19 Sep 2024 04:01

Export record

Contributors

Author: Thomas Phillips
Author: Scott Harris
Author: Olalekan Lee Aiyegbusi
Author: Bethany Lucas
Author: Melissa Benavente
Author: Paul Cockwell
Author: Philip A. Kalra
Author: David C. Wheeler
Author: Maarten W. Taal

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×